Researchers identified 33 metabolic compounds in blood samples that differed between those with dementia and cognitively healthy older adults. 7 of the metabolites were elevated in dementia patients, while 26 were at lower levels compared to samples of those without dementia. Elevating levels of those metabolites could have a neuroprotective effect against dementia.
Artificial IntelligenceDeep LearningFeaturedMachine LearningNeuroscienceOpen Neuroscience ArticlesPsychology··5 min read
Blood tests revealed specific epigenetic biomarkers for schizophrenia. Researchers applied machine learning to analyze the CoRSIVs region of the human genome to identify the schizophrenia biomarkers. Testing the model with an independent data set revealed the AI technology can detect schizophrenia with 80% accuracy.
A newly developed blood test is 96% accurate in the early detection of Alzheimer's disease.
A new algorithm that uses data from memory tests and blood samples is able to accurately predict an individual's risk for developing Alzheimer's disease.
Higher baseline levels of N-terminal fragment of tau in the blood of healthy subjects was associated with an increased risk of developing cognitive deficits and Alzheimer's disease later in life.
A new blood test could help doctors monitor those who are at risk of developing psychiatric disorders. The test looks for specific protein biomarkers in blood samples of those with risk factors for psychiatric illnesses and can help to predict who is most likely to develop psychosis in the future.
Researchers have developed a blood test that looks at genetic markers to detect which babies who were deprived of oxygen at birth are at risk of developing neurodevelopment problems.
A new blood test can help predict which patients with multiple sclerosis will see a decline in their condition over 12 months. The test looks for a biomarker called neurofilament light chain, a protein that can be detected as nerve cells die. People with higher levels of the protein were 40-70% more likely to experience worsening symptoms over a year than those with lower levels.
Increased levels of PHGDH exRNA levels were found in the blood approximately two years before people were clinically diagnosed with Alzheimer's disease.
Study will analyze dried blood spots from newborns for over 1,000 different chemicals and molecules. The presence of some of the molecules may predict autism risk years before symptoms appear, allowing for early treatment and possible prevention.